<DOC>
	<DOCNO>NCT00821860</DOCNO>
	<brief_summary>RATIONALE : Video-assisted surgery remove part tissue layer cover inside chest cavity may effective treat pleural effusion cause less damage normal tissue . Talc pleurodesis may keep fluid building chest cavity . It yet know therapy effective treat pleural effusion cause malignant mesothelioma . PURPOSE : This randomized phase III trial study video-assisted surgery see well work compare talc pleurodesis treat patient malignant mesothelioma .</brief_summary>
	<brief_title>Video-Assisted Surgery Talc Pleurodesis Treating Patients With Malignant Mesothelioma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare effectiveness video-assisted thoracoscopic cytoreductive pleurectomy v talc pleurodesis , term 1-year survival , patient suspect proven malignant mesothelioma . Secondary - Compare control pleural effusion patient . - Compare procedure-related complication patient . - Compare symptom quality life patient 3 , 6 , 12 month treatment . - Compare length hospital stay patient . - Compare exercise tolerance patient 3 , 6 , 12 month treatment . - Determine cost health service , term resource use procedure , hospital bed usage , cost primary secondary care 12 month . OUTLINE : This multicenter study . Patients stratify accord risk ( high vs low ) . Patients randomize 1 2 treatment arm . - Arm I ( video-assisted thoracoscopic [ VAT ] cytoreductive pleurectomy ) : Patients undergo VAT cytoreductive pleurectomy either time biopsy confirmation biopsy result . - Arm II ( talc pleurodesis ) : Patients undergo talc pleurodesis via indwell intercostal chest drain via thoracoscopy either time biopsy confirmation biopsy result . Quality life , complication , resource use assess baseline 1 , 3 , 6 , 12 month .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Confirmed suspect mesothelioma Any subtype allow Pleural effusion must present PATIENT CHARACTERISTICS : Clinically fit suitable videoassisted thoracoscopic cytoreductive pleurectomy Prior malignancy allow provide longer require treatment AND patient confirm diagnosis mesothelioma PRIOR CONCURRENT THERAPY : No prior attempt pleurodesis approach</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>epithelial mesothelioma</keyword>
	<keyword>recurrent malignant mesothelioma</keyword>
	<keyword>sarcomatous mesothelioma</keyword>
	<keyword>malignant pleural effusion</keyword>
	<keyword>stage IA malignant mesothelioma</keyword>
	<keyword>stage IB malignant mesothelioma</keyword>
	<keyword>stage II malignant mesothelioma</keyword>
	<keyword>stage III malignant mesothelioma</keyword>
	<keyword>stage IV malignant mesothelioma</keyword>
</DOC>